Conrad Wai Clover Health Investments, Corp. (CLOV) insider trading activity

Conrad Wai is CEO, Counterpart Health of CLOVER HEALTH INVESTMENTS, CORP. . Currently has a direct ownership of 1.27 Million shares of CLOV, which is worth approximately $3.72 Million. The most recent transaction as insider was on Oct 15, 2025, when has been sold 92,181 shares (Class A Common Stock) at a price of $2.8 per share, resulting in proceeds of $258,106. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.27M

59.39% 3M change

64.38% 12M change

Total Value Held $3.72 Million

Conrad Wai Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 15 2025	SELL Payment of exercise price or tax liability	$258,106 $2.8 p/Share	92,181 Reduced 6.75%	1,274,463 Class A Common Stock
Sep 14 2025	SELL Payment of exercise price or tax liability	$301,140 $3.06 p/Share	98,412 Reduced 5.89%	1,573,425 Class A Common Stock
Jul 31 2025	SELL Payment of exercise price or tax liability	$80,717 $2.89 p/Share	27,930 Reduced 1.64%	1,671,837 Class A Common Stock
Jun 14 2025	SELL Payment of exercise price or tax liability	$284,407 $2.89 p/Share	98,411 Reduced 3.04%	3,138,535 Class A Common Stock
Apr 30 2025	SELL Payment of exercise price or tax liability	$90,416 $3.4 p/Share	26,593 Reduced 0.81%	3,236,946 Class A Common Stock
Mar 14 2025	SELL Payment of exercise price or tax liability	$294,717 $3.66 p/Share	80,524 Reduced 2.41%	3,263,539 Class A Common Stock
Jan 31 2025	SELL Payment of exercise price or tax liability	$107,423 $4.39 p/Share	24,470 Reduced 0.73%	3,344,063 Class A Common Stock
Dec 14 2024	SELL Payment of exercise price or tax liability	$305,454 $3.11 p/Share	98,217 Reduced 2.83%	3,368,533 Class A Common Stock
Oct 31 2024	SELL Payment of exercise price or tax liability	$459,363 $4.12 p/Share	111,496 Reduced 3.12%	3,466,750 Class A Common Stock
Oct 15 2024	BUY Grant, award, or other acquisition	-	726,114 Added 16.87%	3,578,246 Class A Common Stock
Sep 14 2024	SELL Payment of exercise price or tax liability	$293,668 $2.99 p/Share	98,217 Reduced 3.33%	2,852,132 Class A Common Stock
Sep 13 2024	SELL Payment of exercise price or tax liability	$278,608 $2.99 p/Share	93,180 Reduced 3.06%	2,950,349 Class A Common Stock
Sep 13 2024	BUY Grant, award, or other acquisition	-	189,934 Added 5.87%	3,043,529 Class A Common Stock
Jun 14 2024	SELL Payment of exercise price or tax liability	$75,371 $1.09 p/Share	69,148 Reduced 2.37%	2,853,595 Class A Common Stock
Mar 14 2024	SELL Payment of exercise price or tax liability	$54,309 $0.73 p/Share	74,396 Reduced 2.48%	2,922,743 Class A Common Stock
Dec 14 2023	SELL Payment of exercise price or tax liability	$96,086 $1.0 p/Share	96,086 Reduced 3.11%	2,997,139 Class A Common Stock
Sep 14 2023	SELL Payment of exercise price or tax liability	$108,577 $1.13 p/Share	96,086 Reduced 3.49%	2,653,225 Class A Common Stock
Jun 14 2023	SELL Payment of exercise price or tax liability	$81,557 $0.94 p/Share	86,763 Reduced 3.06%	2,749,311 Class A Common Stock

Conrad Wai

CEO, Counterpart Health

Franklin, TN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CLOV shares.

Notify only if

Value

Insider Trading

Get notified when an Clover Health Investments, Corp. insider buys or sells CLOV shares.

Notify only if

Operation

Value

Type

News

Receive news related to CLOVER HEALTH INVESTMENTS, CORP.

Track Activities on CLOV

Account